Showing results (241-250 of 20,613) with videos related to

Sort By:
Pageof 2,062
Biochemical Pharmacology|September 29, 2025
Roles and therapeutic potential of PARP-1 in neurodegenerative diseasesChang Liu, Fei-Fan Lai, Ting Zhang, et al.
Biochemical Pharmacology|September 22, 2025
ETV5 transcriptionally inhibits KIF23 to repress pyroptosis in aged mice with perioperative neurocognitive disordersShaoqun Tang, Xueshan Bu, Xi Yu, et al.
Biochemical Pharmacology|September 21, 2025
Tanshinone IIA suppresses endoplasmic reticulum stress-mediated IRE1α/TXNIP/NLRP3 pathway to mitigate pyroptosis in type 2 diabetic osteoporosisZhuojun Jiang, Jiancao Zuo, Hailan Luo, et al.
Biochemical Pharmacology|September 25, 2025
A synergic GLP-1/Acylethanolamide-based combined therapy for MAFLD: Studies in rat modelsMarialuisa de Ceglia, Rubén Tovar, Miguel Rodríguez-Pozo, et al.
Biochemical Pharmacology|September 24, 2025
The oral microbiome-redox-inflammation axis in neurodegeneration: mechanistic insights and therapeutic perspectivesThi Thuy Tien Vo, Ming-Horng Tsai, Chueh-Yi Cheng, et al.
Biochemical Pharmacology|May 26, 2024
Targeting ONECUT2 inhibits tumor angiogenesis via down-regulating ZKSCAN3/VEGFALigang Zhang, Cunjie Li, Xinran Song, et al.
Biochemical Pharmacology|December 19, 2020
Adenosine metabolism in the vascular systemGennady G Yegutkin
Biochemical Pharmacology|December 28, 2020
The neurobiological underpinning of the circadian wake signalJamie M Zeitzer
Biochemical Pharmacology|December 28, 2020
Purinergic signalling in the kidney: In physiology and diseaseMarie-Louise T Monaghan, Matthew A Bailey, Robert J Unwin
Biochemical Pharmacology|December 28, 2020
Negative correlation of urinary miR-199a-3p level with ameliorating effects of sarpogrelate and cilostazol in hypertensive diabetic nephropathySeung Ki Kim, Geon Kim, Bo-Hyun Choi, et al.
Pageof 2,062